Cargando…

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)

BACKGROUND: Several recent randomized therapeutic exploratory trials demonstrated improvement of progression-free survival and in some even overall survival using stereotactic body radiotherapy in patients with oligometastatic disease. However, only very few patients enrolled in these trials had bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krug, David, Vonthein, Reinhard, Illen, Alicia, Olbrich, Denise, Barkhausen, Jörg, Richter, Julia, Klapper, Wolfram, Schmalz, Claudia, Rody, Achim, Maass, Nicolai, Bauerschlag, Dirk, Heßler, Nicole, König, Inke R., Dellas, Kathrin, Dunst, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065185/ https://www.ncbi.nlm.nih.gov/pubmed/33912695 http://dx.doi.org/10.1016/j.ctro.2021.03.012

Ejemplares similares

Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial
por: Krug, David, et al.
Publicado: (2020)

Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)
por: Blanck, Oliver, et al.
Publicado: (2020)

Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study
por: Dellas, Kathrin, et al.
Publicado: (2012)

Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
por: Krug, David, et al.
Publicado: (2023)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial
por: Krug, David, et al.
Publicado: (2023)

Expanded nursing competencies to improve person-centred care for nursing home residents with complex health needs (Expand-Care): study protocol for an exploratory cluster-randomised trial
por: Silies, Katharina Theodora, et al.
Publicado: (2023)

Teaching communication skills in medical education: Best practice example of an interdisciplinary seminar in radiation oncology
por: Schmalz, Claudia, et al.
Publicado: (2023)

Repeatability and reproducibility of various 4D Flow MRI postprocessing software programs in a multi-software and multi-vendor cross-over comparison study
por: Oechtering, Thekla H., et al.
Publicado: (2023)

Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy
por: Vasku, Marketa, et al.
Publicado: (2011)

Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials
por: Pfaffendorf, Charlotte, et al.
Publicado: (2022)

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer
por: Schubert, Melanie, et al.
Publicado: (2023)

Fertility Preservation in Female Patients with Breast Cancer – a Current Overview
por: Guenther, Veronika, et al.
Publicado: (2017)

Patient-Reported Outcomes Assessing the Impact of Palliative Radiotherapy on Quality of Life and Symptom Burden in Head and Neck Cancer Patients: A Systematic Review
por: Fabian, Alexander, et al.
Publicado: (2021)

Definitive Radiotherapie versus Radiochemotherapie mit wöchentlich Docetaxel bei Patienten mit Kopf-Hals-Tumoren und Cisplatinunverträglichkeit
por: Schmalz, Claudia, et al.
Publicado: (2023)

An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial
por: Prasuhn, Jannik, et al.
Publicado: (2019)

Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review
por: Fabian, Alexander, et al.
Publicado: (2022)

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis
por: Hong, Julian C., et al.
Publicado: (2018)

Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04)
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study
por: Romagnoli, Gloria, et al.
Publicado: (2017)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial
por: Jiang, Ping, et al.
Publicado: (2017)

Efficacy of goal-directed minimally invasive surgery simulation training with the Lübeck Toolbox-Curriculum prior to first operations on patients: Study protocol for a multi-centre randomized controlled validation trial (NOVICE)
por: Thomaschewski, Michael, et al.
Publicado: (2020)

Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
por: Baydoun, A., et al.
Publicado: (2021)

Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement Disorders
por: Schmidt, Tamara, et al.
Publicado: (2021)

The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Boost und Hypofraktionierung beim DCIS
por: Dunst, Jürgen, et al.
Publicado: (2022)

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom
por: Dunst, Jürgen, et al.
Publicado: (2022)

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC
por: Krug, David, et al.
Publicado: (2023)

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust
por: Krug, David, et al.
Publicado: (2023)

Erratum to “Efficacy of goal-directed minimally invasive surgery simulation training with the Lübeck Toolbox-Curriculum prior to first operations on patients: Study protocol for a multi-centre randomized controlled validation trial (NOVICE)” [Int. J. Surg. Protoc. 21 (2020) 13–20]
por: Thomaschewski, Michael, et al.
Publicado: (2020)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Surgical treatment in oligometastatic breast cancer
por: Vargas, Catalina, et al.
Publicado: (2019)

Role of surgery in oligometastatic prostate cancer
por: Jenjitranant, Pocharapong, et al.
Publicado: (2019)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

Oligometastatic Breast Cancer: How to Manage It?
por: Barberi, Vittoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8s6j2vctfrtvifldicib8kiab